MYSM1通过降低PARP1的含量来调解心脏帕他那托斯和心脏缩
Xin Zhong1, Jianjiang Xu1, Xiaowen Shi1
1Department of Cardiology, The Second Affiliated Hospital of Jiaxing University, Zhejiang, China (X.Z., Jianjiang Xu, X.S., Y.L., Jiajun Xu, J.H.).
Hypertension (Dallas, Tex. : 1979)
|February 5, 2025
概括
双化酶MYSM1 (Myb-like,SWIRM和MPN域1) 通过稳定PARP1促进心脏缩,导致心肌细胞死亡. 抑制MYSM1为心力衰竭提供了一个潜在的治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 疾病的分子机制.
- 酶学 是一种酶学.
背景情况:
- 心脏缩是心力衰竭,发病率和死亡率的主要驱动因素.
- 脱化酶是蛋白质降解和心脏病理生理学的关键调节者.
- 在此之前,MYSM1 (Myb-like,SWIRM和MPN域1) 在心脏缩中的特定作用尚不清楚.
研究的目的:
- 调查MYSM1在心脏缩的发展中的参与.
- 阐明MYSM1影响心脏缩的潜在分子机制.
主要方法:
- 在动物模型中,使用血管增生素II和横向大动脉收缩手术诱导心脏缩.
- 通过使用腺相关病毒血清型9输送实现了对MYSM1的心肌细胞特异性淘汰.
- 同免疫沉和液态染色学-并联质谱学 (LC-MS) 确定了MYSM1的相互作用蛋白.
主要成果:
- 在心脏缩期间,MYSM1表达被上调.
- 在对刺激的反应中,MYSM1减弱心脏功能障碍和过度缩小的 Knockdown.
- 聚 (ADP-ribose) 聚合酶1 (PARP1) 被确定为MYS1的基质;MYS1二氧化化和稳定PARP1,促进心肌细胞中的帕尔他纳托斯 (编程细胞死亡).
结论:
- MYSM1-PARP1信号轴在调节心脏缩方面发挥着至关重要的作用.
- MYSM1通过PARP1依赖的心肌细胞共生细胞促进心脏缩.
- MYSM1代表了治疗心脏缩和相关心力衰竭的潜在治疗标.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K

